LIMN
Liminatus Pharma, Inc.
Company overview
- Market capitalization
- $281.74M
- Employees
- 1
- Latest publication
- 2026-09-29
About Liminatus Pharma, Inc.
Liminatus Pharma, Inc., a pre-clinical stage biopharmaceutical company, engages in the development of cancer therapies in the United States. It develops IBA101, a humanized anti CD47 monoclonal antibody, which is in Phase I clinical trial for the treatment of advanced solid cancers, including non-small cell lung cancer. The company was founded in 2018 and is based in Cerritos, California.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | — | 0USD | 0USD | — | — |
| Cost Of Revenue | 518USD | — | 542USD | — | — | — | — | — |
| Gross Profit | -518USD | — | -542USD | — | — | — | — | — |
| Research Development | 400,000USD | 0USD | 0USD | — | 0USD | 200USD | 357,066USD | 714,134USD |
| Selling General Administrative | 700,898USD | 884,211USD | 701,170USD | — | 264,220USD | 167,000USD | 186,081USD | 195,084USD |
| Total Operating Expenses | 1,100,898USD | 884,211USD | 701,170USD | — | 255USD | 522,788USD | 1,019,694USD | 642,082USD |
| Operating Income | -1,100,898USD | -884,211USD | -701,170USD | — | -255USD | -522,788USD | -1,019,694USD | -642,082USD |
| Interest Income | 0USD | 0USD | 0USD | — | 52,206USD | 43,526USD | 34,481USD | — |
| Interest Expense | 18,638USD | 19,051USD | 19,052USD | — | 115,512USD | 136,763USD | 92,706USD | 77,220USD |
| Net Interest Income | -18,638USD | -19,051USD | -19,052USD | — | -63,306USD | -62,356USD | -58,225USD | — |
| Income Before Tax | -1,123,714USD | -8,168,927USD | -1,823,351USD | — | -255USD | -865,263USD | -637,737USD | -530,074USD |
| Net Income | -1,123,714USD | -8,168,927USD | -1,823,351USD | — | -255USD | -868,314USD | -642,900USD | -534,854USD |
| Net Income From Continuing Ops | -1,123,714USD | -8,168,927USD | -1,823,351USD | — | -255USD | -229,309USD | -601,372USD | — |
| Ebitda | -1,100,898USD | -8,149,333USD | -1,803,757USD | — | -255USD | -728,500USD | -637,737USD | -530,074USD |
| Reconciled Depreciation | 518USD | 543USD | 542USD | 743USD | 0USD | — | 0USD | — |
| Total Other Income Expense Net | -22,816USD | -7,284,716USD | -1,122,181USD | — | — | -342,474USD | 381,957USD | 112,008USD |
| Ebit | — | -8,149,876USD | -1,804,299USD | — | — | — | — | — |
| Depreciation And Amortization | — | 543USD | 542USD | — | — | — | — | — |
| Income Tax Expense | — | — | — | — | — | 3,051USD | 5,163USD | 4,780USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD |
|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | — |
| Research Development | 0USD | 2,685,000USD | 3,757,000USD | 1,853,000USD | 3,802,000USD |
| Selling General Administrative | 2,967,812USD | 645,000USD | 1,062,000USD | 856,000USD | 197,000USD |
| Total Operating Expenses | 2,967,812USD | 2,906,319USD | 2,586,211USD | 2,709,000USD | 2,534,272USD |
| Operating Income | -2,967,812USD | -2,906,319USD | -2,586,211USD | -2,709,000USD | -2,534,272USD |
| Interest Income | 76,589USD | 122,526USD | 10,000USD | 0USD | — |
| Interest Expense | 215,903USD | 138,102USD | 175,000USD | 219,000USD | — |
| Net Interest Income | -139,314USD | -216,356USD | -165,000USD | -219,000USD | — |
| Income Before Tax | -10,206,517USD | -2,885,458USD | -1,192,231USD | -2,928,000USD | 4,369,659USD |
| Net Income | -10,206,517USD | -2,904,299USD | -1,226,218USD | -2,928,000USD | 4,369,659USD |
| Net Income From Continuing Ops | -10,206,517USD | -3,546,309USD | -4,984,000USD | -2,928,000USD | — |
| Ebit | -9,990,614USD | — | — | — | — |
| Ebitda | -9,988,786USD | -2,747,356USD | -1,089,142USD | -2,709,000USD | 4,369,658USD |
| Depreciation And Amortization | 1,828USD | — | — | — | — |
| Reconciled Depreciation | 1,828USD | 0USD | — | — | — |
| Total Other Income Expense Net | -7,238,705USD | 20,861USD | 1,393,980USD | -219,000USD | 6,903,931USD |
| Income Tax Expense | — | 18,841USD | 33,987USD | 539,823USD | — |
| Unclassified Operating Expenses | — | — | -2,232,789USD | — | -1,464,728USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 3,403,702USD | 2,790,249USD | 512,795USD | 1,342,409USD | 2,828,932USD | 5,408,859USD | 3,068,186USD | 3,535,705USD |
| Total Current Assets | 3,392,467USD | 2,778,546USD | 500,574USD | 1,203,370USD | 812,658USD | 5,281,643USD | 394,187USD | 409,159USD |
| Other Current Assets | 375,371USD | 870,872USD | 162,919USD | 478,868USD | 1,664USD | 155,501USD | 20,250USD | 45,500USD |
| Total Liabilities | 3,103,090USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 3,040,423USD | 2,889,423USD | 10,298,241USD | 2,864,593USD | 1,060USD | 24,748,922USD | 7,535,622USD | 6,468,698USD |
| Total Stockholder Equity | 300,612USD | -132,596USD | -9,814,690USD | -1,645,763USD | -1,060USD | -19,340,063USD | -14,254,998USD | -13,069,526USD |
| Total Equity Including Noncontrolling Interest | 300,612USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 11,235USD | 11,703USD | 12,221USD | 12,764USD | — | 941USD | 1,000USD | — |
| Accounts Payable | 655,089USD | 529,778USD | 582,234USD | 559,171USD | — | 1,483,253USD | 1,172,000USD | — |
| Common Stock | 5,597USD | 4,823USD | 2,706USD | 2,706USD | 1,757,158USD | — | 2,452,853USD | 2,921,999USD |
| Retained Earnings | -41,402,706USD | -39,995,447USD | -38,871,733USD | -30,702,806USD | -1,060USD | -28,665,216USD | -16,642,468USD | -15,994,197USD |
| Total Liab | — | 2,922,845USD | 10,327,485USD | 2,988,172USD | 1,060USD | 24,748,922USD | 17,323,184USD | 16,605,231USD |
| Other Current Liab | — | 1,446,923USD | 8,855,741USD | 862,922USD | 1,060USD | — | 2,963,402USD | 2,696,478USD |
| Capital Stock | — | 4,823USD | 2,706USD | 2,706USD | 0USD | 1,750USD | — | — |
| Cash | — | 1,907,674USD | 337,655USD | 724,502USD | 804,538USD | 56,319USD | 358,181USD | 339,203USD |
| Cash And Short Term Investments | — | 1,907,674USD | 337,655USD | 724,502USD | 804,538USD | — | 358,181USD | 339,203USD |
| Net Debt | — | -465,174USD | 1,104,845USD | 717,998USD | 4,317,682USD | 19,916,681USD | 4,214,039USD | 3,433,017USD |
| Short Term Debt | — | 1,442,500USD | 1,442,500USD | 1,442,500USD | 5,122,220USD | — | 4,572,220USD | 3,772,220USD |
| Short Long Term Debt | — | 1,442,500USD | 1,442,500USD | 1,442,500USD | — | 19,973,000USD | 19,273,000USD | — |
| Short Long Term Debt Total | — | 1,442,500USD | 1,442,500USD | 1,442,500USD | 5,122,220USD | — | 4,572,220USD | 3,772,220USD |
| Common Stock Shares Outstanding | — | 23,753,561shares | 23,753,561shares | 27,007,568shares | 27,064,600shares | 7,074,477shares | 7,173,964shares | 7,187,037shares |
| Non Current Assets Total | — | 11,703USD | 12,221USD | 139,039USD | 2,016,274USD | 127,216USD | 2,673,999USD | 3,126,546USD |
| Non Current Liabilities Total | — | 33,422USD | 29,244USD | 123,579USD | 10,017,399USD | 0USD | 9,787,562USD | 10,136,533USD |
| Net Working Capital | — | -110,877USD | -9,797,667USD | -1,661,223USD | — | -19,467,279USD | -19,238,000USD | — |
| Unclassified Current Liabilities | — | -1,972,278USD | -2,024,734USD | -1,442,500USD | -5,122,220USD | 3,292,669USD | -20,445,000USD | — |
| Unclassified Equity | — | 39,853,205USD | 29,051,631USD | 29,051,631USD | -1,757,148USD | 9,323,403USD | — | — |
| Non Currrent Assets Other | — | — | — | 126,275USD | — | — | -2,547,999USD | — |
| Net Receivables | — | — | — | — | 6,456USD | — | 15,756USD | 24,456USD |
| Accumulated Other Comprehensive Income | — | — | — | — | -10USD | — | -117,669USD | -68,888USD |
| Unclassified Non Current Assets | — | — | — | — | 2,016,274USD | — | 2,672,999USD | 3,126,546USD |
| Unclassified Non Current Liabilities | — | — | — | — | 10,017,399USD | — | 9,787,562USD | 10,136,533USD |
| Unclassified Current Assets | — | — | — | — | — | 5,069,823USD | — | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD |
|---|---|---|---|---|---|
| Total Assets | 512,795USD | 2,828,932USD | 4,502,213USD | 15,488,270USD | 276,438,764USD |
| Other Current Assets | 162,919USD | 1,664USD | -1,168,119USD | -4,787,351USD | 84,438USD |
| Total Liab | 10,327,485USD | 18,698,831USD | 15,194,997USD | 14,194,064USD | 21,569,899USD |
| Total Stockholder Equity | -9,814,690USD | -15,869,899USD | -10,692,784USD | 1,294,206USD | 254,868,865USD |
| Other Current Liab | 8,855,741USD | 2,075,211USD | -11,824,447USD | -13,416,582USD | 871,389USD |
| Common Stock | 2,706USD | 1,757,158USD | 4,050,340USD | 15,128,311USD | 276,000,690USD |
| Capital Stock | 2,706USD | 1,750USD | — | — | — |
| Retained Earnings | -38,871,733USD | -17,518,175USD | -14,883,124USD | -13,974,105USD | -21,131,825USD |
| Cash | 337,655USD | 804,538USD | 434,000USD | 5,048,000USD | 336,228USD |
| Cash And Short Term Investments | 337,655USD | 804,538USD | 434,000USD | 5,048,000USD | 336,228USD |
| Total Current Assets | 500,574USD | 812,658USD | 210,881USD | 360,649USD | 421,922USD |
| Total Current Liabilities | 10,298,241USD | 8,681,431USD | 5,158,553USD | 3,591,418USD | 1,380,389USD |
| Net Debt | 1,104,845USD | 4,317,682USD | 15,616,000USD | 11,452,000USD | -246,228USD |
| Short Term Debt | 1,442,500USD | 5,122,220USD | 16,050,000USD | 16,500,000USD | 90,000USD |
| Short Long Term Debt | 1,442,500USD | 19,973,000USD | 16,050,000USD | 16,500,000USD | — |
| Short Long Term Debt Total | 1,442,500USD | 5,122,220USD | 16,050,000USD | 16,500,000USD | 90,000USD |
| Accounts Payable | 582,234USD | 1,484,000USD | 933,000USD | 508,000USD | 419,000USD |
| Property Plant Equipment Net | 12,221USD | 941USD | 1,000USD | 1,000USD | — |
| Common Stock Shares Outstanding | 23,753,561shares | 7,191,610shares | 8,012,534shares | 34,428,255shares | 34,500,000shares |
| Non Current Assets Total | 12,221USD | 2,016,274USD | 4,291,332USD | 15,127,621USD | 276,016,842USD |
| Non Current Liabilities Total | 29,244USD | 10,017,399USD | 10,036,444USD | 10,602,646USD | 20,189,510USD |
| Net Working Capital | -9,797,667USD | -19,467,279USD | -15,795,000USD | -10,811,000USD | — |
| Unclassified Current Liabilities | -2,024,734USD | -19,973,000USD | -27,874,447USD | -29,916,582USD | — |
| Unclassified Equity | 29,051,631USD | — | — | — | — |
| Net Receivables | — | 6,456USD | 945,000USD | 100,000USD | 1,256USD |
| Accumulated Other Comprehensive Income | — | -160,677USD | — | — | — |
| Unclassified Non Current Assets | — | 2,015,333USD | 4,290,332USD | 15,126,621USD | 276,016,842USD |
| Unclassified Non Current Liabilities | — | 10,017,399USD | 10,036,444USD | 10,602,646USD | 20,189,510USD |
| Non Currrent Assets Other | — | — | -1,000USD | -1,000USD | — |
| Unclassified Current Assets | — | — | -1,168,119USD | -4,787,351USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 986USD |
| Change To Liabilities | -294,084USD |
| Change In Working Capital | -506,536USD |
| Operating Cash Flow | -2,985,288USD |
| Financing Cash Flow | 5,664,729USD |
| Change In Cash | 2,679,441USD |
| End Cash Flow | 3,017,096USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -1,123,714USD | -8,168,927USD | -1,823,351USD | — | -255USD | -868,314USD | -642,900USD | -534,854USD |
| Depreciation | 518USD | 543USD | 542USD | 743USD | 0USD | — | 0USD | — |
| Other Non Cash Items | 4,178USD | 15,274,752USD | 1,103,129USD | — | 255USD | 205,711USD | -481,708USD | -112,008USD |
| Change In Working Capital | -896,271USD | -7,493,215USD | 119,068USD | -7,661,093USD | 255USD | -122,892USD | 395,253USD | -41,028USD |
| Total Cash From Operating Activities | -2,015,289USD | -386,847USD | -600,612USD | -8,816,466USD | -159,393USD | -785,495USD | -729,355USD | -687,890USD |
| Capital Expenditures | 0USD | 0USD | -13,108USD | 0USD | 0USD | -5USD | -5USD | -3USD |
| Free Cash Flow | -2,015,289USD | -386,847USD | -613,720USD | -8,816,466USD | -159,393USD | -785,500USD | -729,360USD | -687,890USD |
| Net Borrowings | 0USD | 0USD | 0USD | 2,327,000USD | 713,000USD | -2,296,077,000USD | 983,000USD | — |
| Total Cash From Financing Activities | 3,585,308USD | 0USD | 11,032,762USD | 10,319,762USD | 713,000USD | 550,000USD | 262,800USD | -465,669USD |
| Change In Cash | 1,570,019USD | -386,847USD | -613,720USD | 1,303,296USD | -21,393USD | 446,357USD | 18,978USD | -1,128,003USD |
| Begin Period Cash Flow | 337,655USD | 724,502USD | 1,338,222USD | 34,926USD | 201,537,000USD | 358,181USD | 339,203USD | 1,467,206USD |
| End Period Cash Flow | 1,907,674USD | 337,655USD | 724,502USD | 1,338,222USD | 1,338,222USD | 804,538USD | 358,181USD | 339,203USD |
| Other Cashflows From Financing Activities | 3,585,308USD | — | 2,563,738USD | — | — | — | — | — |
| Total Cashflows From Investing Activities | — | -775,000USD | -13,108USD | — | — | -57,343USD | 485,533USD | 1,291,225USD |
| Issuance Of Capital Stock | — | 0USD | 0USD | — | — | — | 0USD | — |
| Investments | — | — | -13,108USD | — | — | — | -800,000USD | — |
| Other Cashflows From Investing Activities | — | — | -775,000USD | — | — | -1,802,869USD | 537,200USD | 1,265,669USD |
| Unclassified Financing Cash Flow | — | — | 8,469,024USD | 7,992,762USD | — | 2,296,627,000USD | — | — |
| Unclassified Operating Cash Flow | — | — | — | -1,156,116USD | — | — | — | — |
| Change To Account Receivables | — | — | — | — | — | 9,300USD | 8,700USD | 10,900USD |
| Unclassified Investing Cash Flow | — | — | — | — | — | 1,745,531USD | — | — |
| Sale Purchase Of Stock | — | — | — | — | — | — | -537,200USD | -1,265,669USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD |
|---|---|---|---|---|---|
| Net Income | -10,206,517USD | -2,904,299USD | -4,984,000USD | -2,928,000USD | 4,369,659USD |
| Depreciation | 1,828USD | 0USD | — | — | — |
| Other Non Cash Items | 7,225,666USD | -157,624USD | — | 900,000USD | -6,903,931USD |
| Change To Account Receivables | -3,427,000USD | 48,000USD | — | — | — |
| Change In Working Capital | -6,984,295USD | -44,539USD | 1,639,000USD | 1,159,000USD | 1,318,393USD |
| Total Cash From Operating Activities | -9,963,318USD | -3,106,462USD | -3,345,000USD | -869,000USD | -1,215,879USD |
| Capital Expenditures | -13,108USD | 0USD | 0USD | 0USD | 0USD |
| Free Cash Flow | -9,976,426USD | -3,106,460USD | -3,345,000USD | -869,000USD | -1,215,880USD |
| Total Cashflows From Investing Activities | -788,108USD | 1,968,249USD | -819,000USD | 263,963,913USD | -276,000,000USD |
| Net Borrowings | 3,040,000USD | 3,923,000USD | -450,000USD | 2,417,000USD | — |
| Total Cash From Financing Activities | 11,032,762USD | 1,047,131USD | -450,000USD | 5,917,000USD | 277,552,107USD |
| Issuance Of Capital Stock | 10,556,500USD | 0USD | 0USD | 4,200,000USD | — |
| Change In Cash | 281,336USD | 648,113USD | -4,614,000USD | 5,048,000USD | 336,228USD |
| Begin Period Cash Flow | 56,319USD | 156,425USD | 5,048,000USD | 336,228USD | — |
| End Period Cash Flow | 337,655USD | 804,538USD | 434,000USD | 5,048,000USD | 336,228USD |
| Other Cashflows From Investing Activities | -5,218,500USD | -189,139USD | -698,484USD | -15,127,621USD | — |
| Other Cashflows From Financing Activities | -2,563,738USD | -1,047,131USD | 10,657,185USD | -268,840,913USD | -5,520,000USD |
| Unclassified Investing Cash Flow | 4,443,500USD | 2,157,388USD | — | 279,091,534USD | -276,000,000USD |
| Sale Purchase Of Stock | — | -1,802,869USD | -10,657,185USD | -700,000USD | — |
| Investments | — | — | -819,000USD | 0USD | — |
| Unclassified Financing Cash Flow | — | — | — | 273,040,913USD | 283,072,107USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.